Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. - Wikidata - wikimedia - TriplyDB

Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis.

Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis.

http://www.wikidata.org/entity/Q50723623

about

The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders Long-Term follow up after intra-Uterine transfusionS; the LOTUS study.Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells Immunologic characterization suggests reduced alloimmunization in a murine model of thalassemia intermedia Responder individuality in red blood cell alloimmunization.Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models.A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease.Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs.Risk Factors for Alloimmunisation after red blood Cell Transfusions (R-FACT): a case cohort study.Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease.Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major.Study of possible clinical and laboratory predictors of alloimmunization against red blood cell antigens in cancer patients.CD4 Depletion or CD40L Blockade Results in Antigen-Specific Tolerance in a Red Blood Cell Alloimmunization Model.Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms.Immune Regulation of sickle Cell Alloimmunization.Association of HLA-DRB1 and HLA-DQB1 with red-blood-cell alloimmunization in the Czech population.-318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients.Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice.Immunosuppressants and alloimmunization against red blood cell transfusions.Intensive red blood cell transfusions and risk of alloimmunization.Anti-CD20 Antibody Prevents Red Blood Cell Alloimmunization in a Mouse Model.Antigen Density Dictates Immune Responsiveness following Red Blood Cell Transfusion.Anti-K formation is not associated with the storage time of transfused red blood cells.HLA polymorphisms and risk of red blood cell alloimmunisation in polytransfused patients with sickle cell anaemia.The HLA-DRB1*15 phenotype is associated with multiple red blood cell and HLA antibody responsiveness.Transforming growth factor-β released by apoptotic white blood cells during red blood cell storage promotes transfusion-induced alloimmunomodulation.Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients.HLA-DRB1*07:01 allele is primarily associated with the Diego a alloimmunization in a Brazilian population.HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies.Effect of storage of red blood cells on alloimmunization.Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?Weak D phenotypes and transfusion safety: where do we stand in daily practice?Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection?The Role of the Immunological Synapse in Differential Effects of APC Subsets in Alloimmunization to Fresh, Non-stored RBCs

P2860

Q27000807-E2F75740-D01C-4289-86CC-59E92A53EB12 Q33759870-FB7782FE-0BE9-4AAB-9F2D-30E2E1405BF5 Q33849566-FBC8ABC4-0E3A-4D88-A995-5908CF42C434 Q34228733-9A336131-965C-45EE-8261-5CA5157FDD50 Q34459335-20EDDC96-4FB1-48E4-A26B-CA4B4591EF05 Q34791984-A34E875D-ECF9-4514-916F-C50679D7B8FE Q34792041-9613E140-63B0-4700-9B81-701FF9BB65A0 Q34792068-04A511E7-457A-4693-A3ED-A45C3AA3234B Q35049152-883C873B-FC32-4A27-A544-F050427B4989 Q35776447-72AE3E98-7931-4DB9-930C-A5E5502189AC Q35981825-10940E8C-BE92-450F-8266-842BFCEED552 Q36106307-CDC6DF6E-0892-4396-A89B-4932535663D2 Q36563588-C028489E-8B5B-4627-A557-88ABB9DC983A Q36600107-F9E60930-5594-4CF7-8952-C7DDA971804D Q36745793-65BA406E-5F2D-4271-8128-4EEAE5F63AFA Q37528619-483CE297-1B11-411E-92A7-8695F3ACC9F4 Q38616688-2BF4DC3B-4F5D-415A-ADF3-5F629118E1F3 Q38792156-60FE24B8-0240-4931-AA16-0C242F7F71A8 Q38928447-89D8E0F3-FD02-4608-A496-74F171F5E118 Q39040981-28D1B118-3C6D-4CB5-B382-764215814EDD Q39322455-3B1E9180-C9EE-4E21-AC24-ACB5736EF8CF Q40153727-CFED312A-06BF-4731-8BB4-1505E9EC87BF Q43945814-15239652-ED78-4E08-9376-73199342D82F Q44088536-3CA5D256-E620-4A7E-89C7-9E7BD66B2F50 Q47621588-7A60C03E-64FB-488C-B39A-CE71FA61699A Q48176949-46999B8C-EC1E-4441-9BD7-9A5E06D60A18 Q48237325-BA709218-3516-40FB-B407-89571F14C864 Q50197445-0C569DD1-810E-4CB0-8764-4EFE8BADE6BC Q50239998-469574E3-3526-4C58-98DD-AC6B17FA2AF4 Q50449455-E91C7765-F616-4D51-BE5D-B93E83B52691 Q50450148-6901EC6A-ED32-421B-8621-5119EAC1E04B Q50474053-7C7EE8B8-DDB1-4C7A-8276-484F1732B48F Q50476222-B7F6DABB-E96A-4A9A-A322-CDA826FAF58E Q50493920-8FB5A759-F165-4A9A-9CED-2817FA60A6DC Q50650747-9449BBEC-B814-46CA-A6D8-2D8C24725C9C Q50925277-C4931906-F05A-411D-B53B-68D077C9EBC4 Q54563894-C061492F-155C-49AA-802F-32EF9683A7EB Q57817939-616595EC-99EB-4CBB-9532-F79516DAA879

P2860

Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis.

http://www.wikidata.org/entity/Q50723623

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Relative immunogenicity of Fya ...... class II restriction analysis.

@en

Relative immunogenicity of Fya ...... class II restriction analysis.

@nl

type

label

Relative immunogenicity of Fya ...... class II restriction analysis.

@en

Relative immunogenicity of Fya ...... class II restriction analysis.

@nl

prefLabel

Relative immunogenicity of Fya ...... class II restriction analysis.

@en

Relative immunogenicity of Fya ...... class II restriction analysis.

@nl

P1433

Q50723623-1D17F9FD-A870-4682-AF21-C3ADB61C1DA6

P1476

Q50723623-D7D1FA18-52DD-4335-B578-EB93FE0172E2

P2093

Q50723623-1087209A-58DF-441C-BA7F-B5DC30305380

Q50723623-31433FA6-B005-486A-B447-299A87D1FB9C

Q50723623-4C180B67-658D-4D49-A38F-2E630B1D57DC

Q50723623-5CD994C6-3F41-4F1E-AC44-50CAD6180FBC

Q50723623-6CA001DE-A1D2-40D8-B7A6-08DE6A45060E

Q50723623-AADDE958-44EF-478A-8C0B-391808F98BA9

Q50723623-E4A1BF11-345F-4725-8495-9B4411A9ED91

P2860

Q50723623-08D48F6B-6A73-4CDB-93B8-00577E86E09B

Q50723623-0C09E970-6C5F-49A2-98E4-F2C199C15BD1

Q50723623-24DAAC1B-724A-478E-9B0C-32D117048280

Q50723623-29897B2F-1A1F-4ED0-82CA-2007111D59EF

Q50723623-3A59D57A-280C-4C99-A600-FE04EB8695E7

Q50723623-49139666-FEB8-4182-BD65-F74AA35366A6

Q50723623-52593228-BBD3-43BE-87EE-FD52D9F5317F

Q50723623-5B0C2217-E430-4470-B818-F0EF3CA09D25

Q50723623-60E0400D-0099-4B65-8A8F-7B8998DDFE36

Q50723623-66BC32BE-C211-4FB7-8C54-3BB33E33EB37

P304

Q50723623-12A7D2A4-565C-412B-B57B-84E1E3AA6136

P31

Q50723623-4C224607-F2B8-4202-9F5B-7DE87A2C5173

P356

Q50723623-1A6E370F-DDA5-426B-8DE4-D54F5B61A6DE

P433

Q50723623-47EEF36D-65E1-4333-B324-C4A2A369385B

P478

Q50723623-D45C14D5-1B74-4E4A-8F95-C76E4DE92A65

P577

Q50723623-6F1D1B9C-4F81-4819-9BC9-7DA51FE7AF63

P698

Q50723623-4E65F783-ED84-4F21-BC66-D51A992E2E00

P356

J.1537-2995.2006.00900.X

P1433

P1476

Relative immunogenicity of Fya ...... class II restriction analysis.

@en

P2093

Christophe Tournamille

http://www.w3.org/2001/XMLSchema#string

France Noizat-Pirenne

http://www.w3.org/2001/XMLSchema#string

Françoise Roudot-Thoraval

http://www.w3.org/2001/XMLSchema#string

Hélène Ansart-Pirenne

http://www.w3.org/2001/XMLSchema#string

Philippe Bierling

http://www.w3.org/2001/XMLSchema#string

Philippe Rouger

http://www.w3.org/2001/XMLSchema#string

Pierre-Yves Le Pennec

http://www.w3.org/2001/XMLSchema#string

P2860

Dendritic cells and the control of immunity

Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.

Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism.

CD4+ T cell responses to SSX-4 in melanoma patients.

HLA-DRB1 alleles and Jk(a) immunization.

Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine.

Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness.

The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues.

Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study.

Identification of immunodominant alloreactive T-cell epitopes on the Jka red blood cell protein inducing either Th1 or Th2 cytokine expression.

P304

1328-1333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1537-2995.2006.00900.X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16934068

http://www.w3.org/2001/XMLSchema#string